News
The following is the transcript of an interview with FDA commissioner Dr. Marty Makary that aired on "Face the Nation with ...
Wong says the plan charts a clear path for healthcare improvements and a commitment achieved through collaboration between ...
Robert F. Kennedy Jr. is set to reshape vaccine approval as he pledges to become the top health official in the nation.
In this compelling episode of The Ellis Martin Report, host Ellis Martin engages in a powerful and enlightening conversation with Michael Breen, ...
First Successful Allogeneic Stem Cell Transplant Using Deceased Donor in Blood Cancer Clinical Trial
For the first time ever, a patient has received an allogeneic stem cell transplant using a deceased donor graft as part of a blood cancer clinical trial at Huntsman Cancer Institute at the University ...
Despite receiving a grim prognosis, Mim’s health journey was completely turned around when she was given the chance to join a clinical trial for breast cancer treatments. “There were multiple ...
Lupus has only three approved treatments compared to over 30 for rheumatoid arthritis, due to enrollment challenges in clinical trials. Altruism and personal benefit motivate trial participation ...
Hosted on MSN23d
Their 3 kids kept getting sick. A new gene therapy offered hopeAva Langenhop was always sick. From "the time she was born," she was "just a sick baby," the 9-year-old's mother, Alicia Langenhop, told CBS News. She'd catch any cough or cold. Before she was two ...
Geopacific Resources’ identification of significant copper-gold porphyry potential opens new phase of district-scale exploration at the Woodlark gold project in PNG 14 porphyry copper-gold ...
Share on Pinterest Wegovy resolved liver inflammation in nearly two-thirds of participants in a major clinical trial, twice the rate seen with placebo. Steve Christo-Corbis/Getty Images Wegovy ...
The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial, according to the findings published Wednesday in the New England ...
A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca's long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results